The company is already at close to AUD$120bn market cap. If it were to increase say 5-6 fold from here it would be the largest pharma company in the world by a long shot, far surpassing Pfizer etc. Actually it would be a top 10 global company. I just can’t see it. Nevertheless I also missed the current boom. It’s current PE already bakes in future earnings at $120bn market capital as well. I’d argue their is more downside risk than upside... just my 2 cents. I wouldn’t be buying at this level.
Index funds indiscriminately buy this as they have to. Props it up to a degree given illiquidity and large pension funds shifting to passive index investing given they never beat the index via high paid active managers.
Those who still hold this from the $20s or even pre split/IPO well done. I didn’t and admit I was wrong.
- Forums
- ASX - By Stock
- CSL
- CSL has more upside...
CSL has more upside..., page-19
-
- There are more pages in this discussion • 407 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$283.39 |
Change
-3.270(1.14%) |
Mkt cap ! $137.9B |
Open | High | Low | Value | Volume |
$285.50 | $285.81 | $282.18 | $37.10M | 130.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 29 | $283.38 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$283.40 | 100 | 17 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 40 | 283.300 |
2 | 21 | 283.290 |
1 | 3 | 283.260 |
4 | 45 | 283.250 |
3 | 26 | 283.240 |
Price($) | Vol. | No. |
---|---|---|
283.340 | 103 | 11 |
283.350 | 12 | 2 |
283.360 | 25 | 1 |
283.370 | 1 | 1 |
283.380 | 7 | 2 |
Last trade - 13.28pm 13/11/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online